JPMorgan Chase & Co (JPM)
241.63
+2.62 (1.10%)
JPMorgan Chase & Co. is a leading global financial services firm that provides a wide range of financial solutions to consumers, businesses, and governments
The company offers investment banking, asset management, private banking, and wealth management services while also delivering a full suite of commercial banking products. With a strong emphasis on innovation and technology, JPMorgan Chase plays a pivotal role in the financial market, helping clients navigate complex financial landscapes through expert advice and tailored services. The firm is committed to maintaining its reputation for integrity and professionalism while actively contributing to economic development and community investment.
Previous Close | 239.01 |
---|---|
Open | 237.81 |
Bid | 241.65 |
Ask | 242.00 |
Day's Range | 236.50 - 242.30 |
52 Week Range | 179.20 - 280.25 |
Volume | 19,327,563 |
Market Cap | 744.80B |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | 5.000 (2.07%) |
1 Month Average Volume | 12,126,052 |
News & Press Releases
JPMorgan CEO Jamie Dimon addressed employees at a town hall meeting, discussing his future, diversity efforts, and return-to-office policy.
Via Benzinga · March 22, 2025
The Federal Reserve, often referred to simply as "the Fed," is the central banking system of the United States. Established in 1913, it has played a pivotal role in shaping the nation’s economy through its control of monetary policy, regulation of banks, and response to financial crises. Its history
Via MarketMinute · March 21, 2025
JPMorgan analyst maintains a Neutral rating on Academy Sports, raising the price target to $54, citing growth uncertainty amid macroeconomic challenges.
Via Benzinga · March 21, 2025
JP Morgan analysts question Dyne Therapeutics' strategy for DYNE-101 in DM1, highlighting regulatory uncertainty and investor concerns over data updates.
Via Benzinga · March 21, 2025
JP Morgan raised Syndax's price target to $41, citing strong early Revuforj sales and physician confidence in its use for acute leukemias and NPM1 AML.
Via Benzinga · March 21, 2025
JP Morgan analyst raised KTOS price forecast to $33.00 from $27.00, citing progress in tactical drones, marine support, and hypersonic weapons.
Via Benzinga · March 21, 2025
JP Morgan launches VIX Short-Term Futures ETN to benefit from decreased market volatility, despite market expectations for volatility to continue or increase.
Via Benzinga · March 21, 2025
JP Morgan upgraded FCX to Overweight with price target of $52 from $48, citing sustained premium pricing and supply constraints, and potential protective measures for US copper imports.
Via Benzinga · March 21, 2025
Derek Chase, CEO of Los Angeles-based FLORA+BAST, contends that the unintended consequences of tariffs could push businesses toward more eco-conscious, locally sourced solutions.
Via Benzinga · March 21, 2025
J.P. Morgan, officially known today as JPMorgan Chase & Co. (NYSE:JPM), stands as one of the most influential financial institutions in the world. Its history spans over two centuries, weaving together tales of ambition, innovation, economic crises, and strategic mergers. From its origins as a modest merchant bank to
Via MarketMinute · March 20, 2025
J.P. Morgan analyst John Ivankoe hosted Bloomin' Brands, CAVA Group and others at the Las Vegas forum. A major takeaway: focus on "doing fewer things better" with continued investments in customer and employee experiences. The analyst recommends adding fresh investments in BROS, SBUX, and CAVA, while maintaining cautious optimism on CMG and EAT.
Via Benzinga · March 20, 2025
JPMorgan upgrades Spire Inc. to Overweight, raises price forecast to $85. Analyst cites regulatory improvements in Missouri and positive factors for increased earnings and growth potential.
Via Benzinga · March 20, 2025
JP Morgan analyst maintains Neutral rating on Holley, citing macroeconomic challenges and a softer revenue outlook despite strong EBITDA guidance.
Via Benzinga · March 20, 2025
JPMorgan sees potential in restaurant stocks despite dip in consumer confidence data. Ivankoe upgrades CAVA Group, maintains neutral rating for Yum!
Via Benzinga · March 20, 2025
FIVE stock up on Q4 earnings beat amid exciting earnings season. JPMorgan rates Underweight, Goldman Sachs rates Buy.
Via Benzinga · March 20, 2025
As of this morning, March 20, 2025, JPMorgan Chase & Co. (NYSE: JPM) is experiencing a modest uptick in its stock price. At 10:20:24 AM EDT, the stock is trading at $240.10, reflecting a gain of $0.99, or 0.41%, from its previous close of $239.11.
Via MarketMinute · March 20, 2025
New York, New York--(Newsfile Corp. - March 20, 2025) - Apex Group Ltd. ("the Group"), the leading global financial services...
Via Newsfile · March 20, 2025
JPMorgan analyst sees Nvidia dominating in AI and potentially outgrowing data center spending with next-gen chips and potential AI factory investments.
Via Benzinga · March 20, 2025
While Barclays raised XPeng’s price target to $20 from $7, JPMorgan lowered its target from $35 to $31.
Via Stocktwits · March 20, 2025
JPMorgan Chase Financial Company LLC (“JPMorgan Financial”) announced that today is the first day of trading on NYSE Arca for its Inverse VIX® Short-Term Futures ETNs due March 22, 2045 under the ticker symbol “VYLD” (the “ETNs”). Any payment on the ETNs is fully and unconditionally guaranteed by JPMorgan Chase & Co. (“JPMorgan Chase” or the “Firm”).
By JPMorgan Chase & Co. · Via Business Wire · March 20, 2025
Financial stocks are taking a tumble as the S&P 500 pushes into correction territory. Despite this, these stocks maintain solid fundamentals for the long-term.
Via MarketBeat · March 20, 2025
JPMorgan analysts said SAP stock was “overly dragged down” by a number of “idiosyncratic” factors that impacted the U.S. software sector.
Via Stocktwits · March 20, 2025
Jamie Dimon, CEO of JPMorgan Chase & Co. (NYSE: JPM), expressed his views on the current economic landscape, highlighting concerns over geopolitical tensions and potential tariff impacts.
Via Benzinga · March 20, 2025
This comes ahead of the company’s investor day scheduled for March 25, where new CEO Andy Silvernail is set to field questions about the company’s strategies going forward.
Via Stocktwits · March 20, 2025
JPMorgan analyst Bryan Smilek assigned a ‘Neutral’ rating with a $50 price target.
Via Stocktwits · March 19, 2025